NutriSelect.ai Founder & CEO Dr. Bill Clark joins The Sunny Ray Show to discuss scientific integrity, AI, supplement efficacy, and the future of evidence-based health intelligence.
The supplement industry has made meaningful progress in quality, manufacturing standards, ingredient identity, and label accuracy. But one challenge remains difficult for consumers to answer:
What does the science actually support?
That question was at the center of a recent conversation between Dr. Bill Clark, Founder & CEO of NutriSelect.ai, and Sunny Ray on The Sunny Ray Show.
In the episode, Rebuilding Trust in the Supplement Industry with AI, Dr. Clark traces the path from his early career in marine natural products chemistry and cancer drug discovery through more than three decades of work across dietary supplement R&D, product development, clinical research, certification, entrepreneurship, and education.
Those experiences ultimately converged around a problem that would become the foundation for NutriSelect.ai:
Consumers have access to more health information than ever before, but they still lack a reliable way to distinguish scientific evidence from marketing noise.
Dr. Clark began his scientific career studying marine natural products at the University of California, Santa Cruz, where his research involved discovering and characterizing novel compounds with potential therapeutic activity.
That training established a principle that has remained central throughout his career:
Plausibility is not proof.
A biological mechanism may be interesting. A formulation may be innovative. A product may have a compelling marketing story.
But scientific credibility depends on evidence.
That distinction became increasingly important as Dr. Clark moved into the dietary supplement industry, where he worked across product development, clinical research, certification, and commercialization.
He saw firsthand both the extraordinary potential of the industry and the wide variation in the quality of evidence behind products and claims.
Third-party certification and regulatory systems have helped the industry address important questions around manufacturing quality, identity, contaminants, and label accuracy.
But those systems do not necessarily answer another critical question:
Is the formulation and dose actually supported by meaningful scientific evidence for the intended benefit?
That gap between quality assurance and demonstrated efficacy remains one of the most important unresolved challenges in supplement decision-making.
It is also one of the problems NutriSelect is being built to address.
The challenge is not simply that scientific evidence exists.
The challenge is scale.
No individual scientist can continuously review every relevant clinical study, compare methodologies, evaluate primary and secondary outcomes, assess statistical analyses, track clinically relevant dosages, monitor new publications, and connect those findings to thousands of products and formulations.
Advances in artificial intelligence now make it possible to process and organize that complexity at a scale that was previously impractical.
But AI alone is not the solution.
As Dr. Clark explains in the conversation:
AI is the scaling mechanism, not the scientific standard.
The value comes from combining AI with rigorous methodology, evidence governance, transparency, and scientific oversight.
That is the foundation behind NutriSelect’s broader vision for Precision Supplement Intelligence™.
NutriSelect is being developed as more than a recommendation engine.
Its scientific intelligence architecture is designed to bring together multiple dimensions of supplement evaluation, including:
At the center of this system is NScore™, NutriSelect’s proprietary scientific assessment framework.
The objective is not to produce an arbitrary star rating or AI-generated opinion.
The objective is to create a structured, evidence-based assessment with a transparent scientific foundation beneath it.
The podcast also explores a defining moment in Dr. Clark’s career when a clinical research client sought access to incomplete study data before a trial had concluded.
He refused.
The experience reinforced a principle that now sits at the core of NutriSelect:
Scientific outcomes cannot be determined by commercial pressure.
That principle extends into how NutriSelect is building its partnerships, verification processes, and scoring governance.
Participation cannot buy a better scientific outcome.
Evidence must determine the result.
The long-term vision for NutriSelect extends beyond evaluating individual products.
As the platform evolves, the opportunity is to connect: scientific evidence + product intelligence + individual health context + real-world outcomes into a continuously learning health intelligence system.
That means moving from static recommendations toward a model in which evidence, products, user needs, and eventually real-world data can inform increasingly precise decisions over time.
The goal is simple, even if the technology behind it is not:
Help people make better health decisions with intelligence they can trust.
Watch Dr. Bill Clark on The Sunny Ray Show: Rebuilding Trust in the Supplement Industry with AI
